The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
Background: Disease modifying therapy (DMT) efficacy trials make an essential contribution to the development of evidence-based clinical treatments and practices for people with multiple sclerosis (MS). Meta-analysis is a critical part of this process and provides a powerful tool to assess the effec...
Main Authors: | Suzi B. Claflin, Simon Broadley, Bruce V. Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2018.01150/full |
Similar Items
-
Disability and progression in Afro-descendant patients with multiple sclerosis
by: Juliana Calvet Kallenbach Aurenção, et al. -
Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
by: Katarzyna Kapica-Topczewska, et al.
Published: (2021-02-01) -
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis
by: Francisco Carlos Pérez‐Miralles, et al.
Published: (2021-04-01) -
Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»
by: N. V. Khachanova, et al.
Published: (2019-12-01) -
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
by: Ethel Ciampi, et al.
Published: (2020-05-01)